Unexpected Plasma Gonadal Steroid and Prolactin Levels Across the Mouse Estrous Cycle.


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
17 04 2023
Historique:
received: 28 02 2023
medline: 15 6 2023
pubmed: 11 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

Despite the importance of the mouse in biomedical research, the levels of circulating gonadal steroids across the estrous cycle are not established with any temporal precision. Using liquid chromatography-mass spectrometry, now considered the gold standard for steroid hormone analysis, we aimed to generate a detailed profile of gonadal steroid levels across the estrous cycle of C57BL/6J mice. For reference, luteinizing hormone (LH) and prolactin concentrations were measured in the same samples by sandwich enzyme-linked immunosorbent assay. Terminal blood samples were collected at 8-hour intervals (10 Am, 6 Pm, 2 Am) throughout the 4 stages of the estrous cycle. As expected, the LH surge was detected at 6 Pm on proestrus with a mean (±SEM) concentration of 11 ± 3 ng/mL and occurred coincident with the peak in progesterone levels (22 ± 4 ng/mL). Surprisingly, estradiol concentrations peaked at 10 Am on diestrus (51 ± 8 pg/mL), with levels on proestrus 6 Pm reaching only two-thirds of this value (31 ± 5 pg/mL). We also observed a proestrus peak in prolactin concentrations (132.5 ± 17 ng/mL) that occurred earlier than expected at 2 Am. Estrone and androstenedione levels were often close to the limit of detection (LOD) and showed no consistent changes across the estrous cycle. Testosterone levels were rarely above the LOD (0.01 ng/mL). These observations provide the first detailed assessment of fluctuating gonadal steroid and reproductive hormone levels across the mouse estrous cycle and indicate that species differences exist between mice and other spontaneously ovulating species.

Identifiants

pubmed: 37165692
pii: 7159815
doi: 10.1210/endocr/bqad070
pmc: PMC10225909
pii:
doi:

Substances chimiques

Prolactin 9002-62-4
Luteinizing Hormone 9002-67-9
Estradiol 4TI98Z838E
Progesterone 4G7DS2Q64Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Welcome Trust
ID : 212242/Z/18/Z

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

Auteurs

Ellen G Wall (EG)

Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.

Reena Desai (R)

ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia.

Zin Khant Aung (Z)

Centre for Neuroendocrinology, University of Otago School of Biomedical Sciences, Dunedin 9014, New Zealand.

Shel Hwa Yeo (SH)

Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.

David R Grattan (DR)

Centre for Neuroendocrinology, University of Otago School of Biomedical Sciences, Dunedin 9014, New Zealand.

David J Handelsman (DJ)

ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia.

Allan E Herbison (AE)

Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH